William F. Ebling

1.8k total citations
47 papers, 1.4k citations indexed

About

William F. Ebling is a scholar working on Anesthesiology and Pain Medicine, Pharmacology and Pharmacology. According to data from OpenAlex, William F. Ebling has authored 47 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Anesthesiology and Pain Medicine, 10 papers in Pharmacology and 9 papers in Pharmacology. Recurrent topics in William F. Ebling's work include Anesthesia and Sedative Agents (17 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). William F. Ebling is often cited by papers focused on Anesthesia and Sedative Agents (17 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). William F. Ebling collaborates with scholars based in United States, Japan and Sweden. William F. Ebling's co-authors include Sandeep Dutta, Donald R. Stanski, William J. Jusko, Stanley J. Szefler, Yoshiaki Matsumoto, William J. Jusko, Amarnath Sharma, Sandra R. Harapat, Gerhard Levy and Daisuke Wada and has published in prestigious journals such as Blood, The American Journal of Medicine and Anesthesiology.

In The Last Decade

William F. Ebling

47 papers receiving 1.3k citations

Peers

William F. Ebling

APM

PHARM

SURGE

PHARM

Jay Ham United States

Yukio Horai Japan

Thomas K. Henthorn United States

David L. Roerig United States

Achiel Van Peer Belgium

Julie Ducharme Canada

A. J. J. Wood United States

Koujirou Yamamoto Japan

Daisuke Wada Japan

I. D. Cockshott United Kingdom

Jay Ham United States

William F. Ebling

492 ×1.2

APM

141 ×0.6

PHARM

256 ×1.2

243 ×1.3

SURGE

296 ×1.6

PHARM

Citations per year, relative to William F. Ebling William F. Ebling (= 1×) peers Jay Ham

Countries citing papers authored by William F. Ebling

Since Specialization

Citations

This map shows the geographic impact of William F. Ebling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William F. Ebling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William F. Ebling more than expected).

Fields of papers citing papers by William F. Ebling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William F. Ebling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William F. Ebling. The network helps show where William F. Ebling may publish in the future.

Co-authorship network of co-authors of William F. Ebling

This figure shows the co-authorship network connecting the top 25 collaborators of William F. Ebling. A scholar is included among the top collaborators of William F. Ebling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William F. Ebling. William F. Ebling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murphy, Joseph G., R. Scott Wright, Ihor Gussak, et al.. (2003). The Use of Roxifiban (DMP754), a Novel Oral Platelet Glycoprotein IIb/IIIa Receptor Inhibitor, in Patients with Stable Coronary Artery Disease. American Journal of Cardiovascular Drugs. 3(2). 101–112. 13 indexed citations

Pieniaszek, Henry J., Sherwin K. B. Sy, William F. Ebling, et al.. (2002). Safety, Tolerability, Pharmacokinetics, and Time Course of Pharmacologic Response of the Active Metabolite of Roxifiban, XV459, a Glycoprotein IIb/IIIa Antagonist, following Oral Administration in Healthy Volunteers. The Journal of Clinical Pharmacology. 42(7). 738–753. 13 indexed citations

Fossler, Michael J., William F. Ebling, David M. Kornhauser, et al.. (2002). Integrated Pharmacokinetic/Pharmacodynamic Model of XV459, a Potent and Specific GPIIb/IIIa Inhibitor, in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 42(12). 1326–1334. 7 indexed citations

Barrett, Jeffrey S., Jun Yu, Ram P. Kapil, et al.. (1999). Disposition and exposure of the fibrinogen receptor antagonist XV459 on αIIBβ3 binding sites in the guinea pig. Biopharmaceutics & Drug Disposition. 20(6). 309–318. 6 indexed citations

Dutta, Sheetij, et al.. (1998). Steady-state propofol brain:plasma and brain:blood partition coefficients and the effect-site equilibration paradox. British Journal of Anaesthesia. 81(3). 422–424. 36 indexed citations

Wada, Daisuke, et al.. (1997). Computer Simulation of the Effects of Alterations in Blood Flows and Body Composition on Thiopental Pharmacokinetics in Humans . Anesthesiology. 87(4). 884–899. 63 indexed citations

Harashima, Hideyoshi, William F. Ebling, Daisuke Wada, & Donald R. Stanski. (1997). No effect of age on the dose requirement of thiopental in the rat. Experimental Gerontology. 32(3). 315–324. 2 indexed citations

Dutta, Sandeep & William F. Ebling. (1997). Parameter Estimability of Biphasic Response Models. Journal of Pharmaceutical Sciences. 86(1). 44–51. 9 indexed citations

Dutta, Sandeep, et al.. (1997). Concentration–EEG Effect Relationship of Propofol in Rats. Journal of Pharmaceutical Sciences. 86(1). 37–43. 48 indexed citations

10.

Ko, Hui C., William J. Jusko, & William F. Ebling. (1997). Nonlinear perpendicular least-squares regression in pharmacodynamics. Biopharmaceutics & Drug Disposition. 18(8). 711–716. 4 indexed citations

11.

Dutta, Sandeep, Yoshiaki Matsumoto, & William F. Ebling. (1996). Is It Possible To Estimate the Parameters of the Sigmoid Emax Model with Truncated Data Typical of Clinical Studies?. Journal of Pharmaceutical Sciences. 85(2). 232–239. 51 indexed citations

12.

Ebling, William F., et al.. (1996). High-performance liquid chromatographic assay of propofol in human and rat plasma and fourteen rat tissues using electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 678(2). 279–288. 26 indexed citations

13.

Ebling, William F. & Gerhard Levy. (1996). Population Pharmacodynamics: Strategies for Concentration- and Effect-Controlled Clinical Trials. Annals of Pharmacotherapy. 30(1). 12–19. 11 indexed citations

14.

Gustafsson, Lars L., et al.. (1996). Quantitation of Depth of Thiopental Anesthesia in the Rat. Anesthesiology. 84(2). 415–427.. 52 indexed citations

15.

Stanski, Donald R., et al.. (1994). Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models. Journal of Pharmacokinetics and Biopharmaceutics. 22(5). 381–410. 52 indexed citations

16.

Ebling, William F., et al.. (1994). From piecewise to full physiologic pharmacokinetic modeling: Applied to thiopental disposition in the rat. Journal of Pharmacokinetics and Biopharmaceutics. 22(4). 259–292. 80 indexed citations

17.

Levy, Gerhard, William F. Ebling, & Alan Forrest. (1994). Concentration- or effect-controlled clinical trials with sparse data. Clinical Pharmacology & Therapeutics. 56(1). 1–8. 46 indexed citations

18.

Björkman, Sven, Donald R. Stanski, Hideyoshi Harashima, et al.. (1993). Tissue distribution of fentanyl and alfentanil in the rat cannot be described by a blood flow limited model. Journal of Pharmacokinetics and Biopharmaceutics. 21(3). 255–279. 46 indexed citations

19.

Verotta, Davide, et al.. (1989). A semiparametric approach to physiological flow models. Journal of Pharmacokinetics and Biopharmaceutics. 17(4). 463–491. 23 indexed citations

20.

Ebling, William F., et al.. (1989). High-performance liquid chromatographic method for determining thiopental concentrations in twelve rat tissues: Application to physiologic modeling of disposition of barbiturate. Journal of Chromatography B Biomedical Sciences and Applications. 490(2). 339–353. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact